期刊文献+

卫生部全国细菌耐药监测网2010年门诊来源细菌耐药监测 被引量:5

Ministry of Health National Antimicrobial Resistant Investigation Net annual report of 2010: bacterial drug resistance surveillance of outpatients
在线阅读 下载PDF
导出
摘要 目的总结我国2010年门诊患者分离细菌的分布与耐药状况。方法监测2010年度卫生部全国细菌耐药监测网所属医院临床分离细菌耐药状况,采用标准纸片扩散法或自动化临床微生物测定方法,测定细菌敏感性,依据CLSI2010年标准,用WHONET 5.6软件进行数据分析。结果按照监测方案129所医院共获得临床分离菌17002株。其中,革兰阴性菌10009株(占58.9%);革兰阳性菌6993株(占41.1%)。耐甲氧西林金黄色葡萄球菌及凝固酶阴性葡萄球菌检出率分别为30.9%和73.1%;未发现万古霉素耐药葡萄球菌。粪肠球菌和屎肠球菌对万古霉素耐药率分别为0.3%和0.7%;未发现利奈唑胺耐药肠球菌。有2.4%的大肠埃希菌和4.5%的肺炎克雷伯菌对亚胺培南耐药。铜绿假单胞菌对碳青酶烯类的耐药率接近20%,与去年相近;鲍曼不动杆菌对米诺环素耐药率为20.1%,对头孢哌酮/舒巴坦耐药率为26.4%,对其他抗菌药物耐药率为50%~75%。结论我国门诊来源分离菌株较去年增加近1倍,耐药情况与上一年度相似,需引起重视。 Objective To explore the bacterial drug resistance and its epidemic trend in outpatients in China for clinical reference in the use of antibacterial agents. Methods All of the bacterial susceptibility results from 129 tertiary care hospitals in Mohnarin from Jan 1 to Dec 31, 2010 were collected by unified protocol and the data were analyzed by software WHONET 5.6. The disc - diffusion or automatic clinical microbiological system method was used for the bacterial sensitivity. Results A total of 17002 bacterial isolates and their antibacterial susceptibility data were collected during the survey period in 129 hospitals, which included 10009 (58.9%) Gram - negative bacterial strains and 6993 (41.1%) Gram - positive bacterial strains. The incidences of methicillin - resistant S. aureus ( MRSA ) and coagulase negative Staphylococcus ( MRSCN ) were 30. 9% and 71.1%, respectively. No vancomycin resistant Staphy- lococcus strains were found. There were 0. 3% of Enterococcus faecalis and 0. 7% of Enterococcusfaecium resistant to vancomycin. No linezolid resistant Enterococcus strains were found. Isolates of Enterobacteriaceae were still highly sensitive to imipenem and meropenem. The average resistance rates were less than 5%. About 20% of P. aeruginosa strains were resistant to the two carbapenems. 20. 1% and 26.4% of A. baumannii were resistant to minocycline and cefoperazone - sulbactam, Conclusion Bacterial resistance in outpatients was common and bacterial year.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2011年第12期899-904,912,共7页 The Chinese Journal of Clinical Pharmacology
关键词 门诊患者 细菌耐药 监测 outpatients bacterial resistance surveillance while 50% -75% resistance rate was to the other drugs. similar to that in last
  • 相关文献

参考文献6

二级参考文献24

  • 1马越,金少鸿.细菌耐药性监测中质量控制的若干问题[J].中华检验医学杂志,2004,27(11):721-723. 被引量:55
  • 2李家泰,李耘,齐慧敏,代表中国细菌耐药监测研究组.2002—2003年中国革兰阴性细菌耐药性监测研究[J].中华检验医学杂志,2005,28(1):19-29. 被引量:296
  • 3张小江,徐英春,俞云松,杨青,汪复,朱德妹,倪语星,孙景勇,孙自镛,简翠,胡云建,艾效曼,张泓,李万华,贾蓓,黄文祥,王传清,王爱敏,魏莲花,吴玲,卓超,苏丹虹,张朝霞,季萍,徐元宏,熊自忠,沈继录,单斌,杜艳.2009年中国CHINET鲍曼不动杆菌细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):441-446. 被引量:137
  • 4XIONG Zi-zhong ZHU De-mei WANG Fu ZHANG Ying-yuan.CTX-M-14, CTX-M-24 and resistance in Escherichia coli and Klebsiella pneumoniae clinical isolates[J].Chinese Medical Journal,2006(2):160-164. 被引量:13
  • 5McGowan JE. Resistance in nonfermenting gram - negative bacteria: multidrug resistance to the maximum [ J ]. Associat Profess Infect Control Epidemiol, 2006; 34( Suppl. 1 ) : S29 -S37.
  • 6Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; nineteenth informational supplement. Wayne: Clinical and Laboratory Standards Institute, 2009.
  • 7Clinical and Laboratory Standard Institute. Performance standards for antimicrobial susceptibility testing; nineteenth informational supplement. Wayne: Clincial and Laboratory Standards Institute, 2009.
  • 8Zhu X, Zheng B, Wang S, et aL Molecular characterization of outbreak - related strains of vancomycin - resistant Enterococcus faecium from an intensive care unit in Beijing, Chin[J]. J Hosp lnfec, 2009; 72 : 147 - 154.
  • 9Turmer PJ. MYSTIC Europe 2007 : activity of meropenem and other broad - spectrum agents against nosocomial isolates [ J ]. Diag Microb Infect Dis ,2009 ; 63 : 217 - 222.
  • 10Bouchillon SK, Iredell JR, Barkham T, et al. Comparative in vitro activity of tigecycline and other antimicrobials against Gram - negative and Gram - positive organisms collected from the Asia - Pacific Rim as part of the Tigecycline Evaluation and Surveillance Trial (TEST) [J]. Int JAntimicrob Agents, 2009; 33:130 -136.

共引文献107

同被引文献43

  • 1Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing; Twenty - First informational sup- plement 2011. Clinical and Laboratory Standards Institute, 2011.
  • 2Antibiotic Resistance Threats in the United States[EB/OL].Centers for Disease Control and Prevention,2013[2014-04-28].http://www.cdc.gov/features/AntibioticResistanceThreats/index,html.
  • 3Wang G,Jiang ZW,Zhao K,et al.Immunologic response after laparoscopic colon cancer operation within an enhanced recovery program[J].J Gastrointest Su rg,2012,16 (7):1379-1388.
  • 4Duncan CJ,Barr DA,Seaton RA.Outpatient parenteral antimicrobial therapy with ceftriaxone,a review[J].Int J Clin Pharm,2012,34(3):410-417.
  • 5Bai ZG,Bao XJ,Cheng WD,et al.Efficacy and safety of ceftriaxone for uncomplicated gonorrhoea:a meta-analysis of randomized controlled trials[J].Int J STD AIDS,2012,23(2):126-132.
  • 6Patel UC,Mc Kissic EL,Kasper D,et al.Outcomes of ceftriaxone use compared to standard of therapy in methicillin susceptible staphylococcal aureus(MSSA)bloodstream infections[J].Int J Clin Pharm,2014,36(6):1282-1289.
  • 7Tratselas A,Simitsopoulou M,Giannakopoulou A,et al.Effect of ceftriaxone on the outcome of murine pyelonephritis caused by extended-spectrum-β-lactamase-producing Escherichia coli[J].Antimicrob Agents Chemother,2014,58(12):7102-7111.
  • 8Kargar M,Kargar M,Jahromi MZ,et al.Molecular detection of ESBLs production and antibiotic resistance patterns in Gram negative bacilli isolated from urinary tract infections[J].Indian J Pathol Microbiol,2014,57(2):244-248.
  • 9黎介寿.对肠功能障碍的再认识[J].肠外与肠内营养,2008,15(6):321-322. 被引量:97
  • 10李刚,李幼生,黎介寿.肠功能障碍的新概念:急性肠损伤与急性肠伤害综合征[J].肠外与肠内营养,2010,17(5):302-305. 被引量:17

引证文献5

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部